Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125702852 | 12570285 | 2 | F | 2015 | 20160729 | 20160719 | 20160803 | EXP | FR-PFIZER INC-2016341147 | PFIZER | 58.00 | YR | F | Y | 0.00000 | 20160803 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125702852 | 12570285 | 1 | PS | Effexor LP | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, DAILY | Y | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | ||||||
| 125702852 | 12570285 | 2 | SS | XANAX | ALPRAZOLAM | 1 | Oral | ONE TABLET IN THE MORNING, HALF A TABLET AT NOON AND ONE TABLET IN THE EVENING | Y | 18276 | TABLET | TID | |||||||
| 125702852 | 12570285 | 3 | SS | IMOVANE | ZOPICLONE | 1 | Oral | 7.5 MG, DAILY | Y | 0 | 7.5 | MG | |||||||
| 125702852 | 12570285 | 4 | SS | VALDOXAN | AGOMELATINE | 1 | Oral | 25 MG, 1X/DAY | Y | 0 | 25 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125702852 | 12570285 | 1 | Depression |
| 125702852 | 12570285 | 2 | Depression |
| 125702852 | 12570285 | 3 | Depression |
| 125702852 | 12570285 | 4 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125702852 | 12570285 | DS |
| 125702852 | 12570285 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125702852 | 12570285 | Acute respiratory failure | |
| 125702852 | 12570285 | Chronic respiratory failure | |
| 125702852 | 12570285 | Cyanosis | |
| 125702852 | 12570285 | Dyspnoea | |
| 125702852 | 12570285 | Interstitial lung disease | |
| 125702852 | 12570285 | Oxygen saturation decreased | |
| 125702852 | 12570285 | Pulmonary hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125702852 | 12570285 | 1 | 201307 | 201505 | 0 | |
| 125702852 | 12570285 | 2 | 201505 | 0 | ||
| 125702852 | 12570285 | 3 | 201505 | 0 | ||
| 125702852 | 12570285 | 4 | 2010 | 201505 | 0 |